AbCellera Biologics Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
AbCellera Biologics Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2020 to Q4 2023.
  • AbCellera Biologics Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $33.8M, a 152% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $33.8M +$20.4M +152% Dec 31, 2023 10-K 2024-02-20
Q4 2022 $13.4M +$4.18M +45.3% Dec 31, 2022 10-K 2024-02-20
Q4 2021 $9.23M +$8.47M +1104% Dec 31, 2021 10-K 2023-02-21
Q4 2020 $767K Dec 31, 2020 10-K 2022-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.